Home › NDC Lookup › RxCUI directory › RxCUI 1547620

Oritavancin 400 MG Injection [Orbactiv] — RxCUI 1547620

Name: Oritavancin 400 MG Injection [Orbactiv] (RxCUI 1547620)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1547620 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1547620

Official nameOritavancin 400 MG Injection [Orbactiv]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asOrbactiv 400 MG Injection; Orbactiv (as oritavancin diphosphate) 400 MG Injection

FDA products mapped1

Package NDCs mapped1

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Oritavancin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Yes, for most people one infusion is the full course of treatment. Oritavancin stays in your body for a very long time — it has a half-life of about 10 days — so a single dose main...
Why is this just one IV infusion — is that really enough to treat my infection?
The most common ones are nausea, headache, vomiting, and diarrhea — generally manageable. During the infusion itself, you might notice flushing, itching, or rash. More seriously, w...
What side effects should I watch out for after the infusion?

📖 Read our full Oritavancin Injection guide →

🕸️ Concept Web — How Oritavancin 400 MG Injection [Orbactiv] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Oritavancin 400 MG Injection [Orbactiv] RxCUI 1547620 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Oritavancin 1547611 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Orbactiv 1547616 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Oritavancin Injection 1724161 SCDF
- Oritavancin Injectable Product 1547613 SCDG
- Oritavancin Injection [Orbactiv] 1724164 SBDF
- Orbactiv Injectable Product 1547619 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Oritavancin 400 MG Injection 1547615 SCD
- Oritavancin 400 MG 1724160 SCDC
- Oritavancin 400 MG [Orbactiv] 1724163 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Oritavancin 400 MG Injection SCD · 1547615
Oritavancin 400 MG SCDC · 1724160
Oritavancin Injection SCDF · 1724161
Oritavancin Injectable Product SCDG · 1547613

Brand-Name Concepts

Oritavancin 400 MG [Orbactiv] SBDC · 1724163
Oritavancin Injection [Orbactiv] SBDF · 1724164
Orbactiv Injectable Product SBDG · 1547619
Orbactiv BN · 1547616

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 1547620 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
70842-0140-03	3 VIAL, GLASS in 1 CARTON (70842-140-03) / 1 INJECTION, POW...	Orbactiv	Melinta Therapeutics, LLC	2014-09-01

Observed labelers: Melinta Therapeutics, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J2407	Injection, oritavancin	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.